Table 3.
Main effects | Interactions | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZnO | Zn-MHACb | |||||||||||||
Zn sources | Cu sources | Phytasea | CuSO4 | Cu-MHACc | CuSO4 | Cu-MHAC | ||||||||
Items | ZnO | Zn-MHAC | CuSO4 | Cu-MHAC | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes |
BW, kg | ||||||||||||||
Days 0 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.7 | 5.8 | 5.7 | 5.7 |
Days 14 | 8.4 | 8.2 | 8.3 | 8.4 | 8.2 | 8.5 | 8.3 | 8.6 | 8.4 | 8.5 | 8.0 | 8.2 | 8.2 | 8.5 |
Days 28 | 15.2 | 15.1 | 15.1 | 15.3 | 14.6 | 15.8 | 14.6 | 15.9 | 14.3 | 16.1 | 14.7 | 15.3 | 14.8 | 15.9 |
Days 42 | 22.3 | 22.2 | 21.9 | 22.6 | 20.7 | 23.9 | 20.3 | 23.7 | 20.8 | 24.5 | 20.4 | 23.4 | 21.2 | 24.0 |
ADG, g/d | ||||||||||||||
Days 0–14 | 195 | 179 | 183 | 191 | 178 | 196 | 185 | 206 | 188 | 199 | 163 | 178 | 175 | 200 |
Days 14–28 | 484 | 495 | 488 | 491 | 457 | 522 | 451 | 521 | 425 | 539 | 478 | 503 | 474 | 525 |
Days 28–42 | 505 | 507 | 487 | 525 | 432 | 579 | 403 | 558 | 455 | 603 | 409 | 577 | 461 | 579 |
Days 0–28 | 340 | 337 | 336 | 341 | 317 | 359 | 318 | 363 | 307 | 371 | 321 | 340 | 324 | 363 |
Days 0–42 | 400 | 399 | 391 | 408 | 361 | 438 | 350 | 434 | 364 | 453 | 354 | 424 | 375 | 441 |
ADFI, g/d | ||||||||||||||
Days 0–14 | 286 | 269 | 276 | 279 | 276 | 279 | 281 | 296 | 283 | 283 | 269 | 257 | 272 | 277 |
Days 14–28d | 628 | 622 | 629 | 621 | 611 | 640 | 605 | 666 | 579 | 662 | 626 | 619 | 632 | 611 |
Days 28–42e | 952 | 970 | 934 | 988 | 894 | 1,027 | 825 | 1,020 | 910 | 1,052 | 867 | 1,023 | 974 | 1,013 |
Days 0–28 | 456 | 445 | 453 | 449 | 442 | 459 | 443 | 481 | 429 | 472 | 448 | 438 | 450 | 444 |
Days 0–42 | 614 | 615 | 609 | 620 | 587 | 643 | 568 | 656 | 577 | 658 | 584 | 629 | 618 | 628 |
G:F, g/g | ||||||||||||||
Days 0–14 | 0.68 | 0.66 | 0.66 | 0.68 | 0.64 | 0.70 | 0.65 | 0.69 | 0.66 | 0.70 | 0.60 | 0.68 | 0.64 | 0.72 |
Days 14–28f | 0.77 | 0.80 | 0.78 | 0.80 | 0.76 | 0.82 | 0.75 | 0.78 | 0.74 | 0.82 | 0.77 | 0.81 | 0.76 | 0.87 |
Days 28–42 | 0.53 | 0.52 | 0.52 | 0.53 | 0.48 | 0.56 | 0.49 | 0.55 | 0.50 | 0.58 | 0.47 | 0.56 | 0.47 | 0.57 |
Days 0–28 | 0.75 | 0.76 | 0.74 | 0.76 | 0.72 | 0.78 | 0.72 | 0.75 | 0.72 | 0.79 | 0.72 | 0.77 | 0.73 | 0.82 |
Days 0–42 | 0.65 | 0.65 | 0.64 | 0.66 | 0.62 | 0.68 | 0.62 | 0.66 | 0.63 | 0.69 | 0.60 | 0.67 | 0.61 | 0.70 |
aNo and yes represent 0 and 500 FTU/kg phytase in the diets, respectively.
bZn-MHAC represents Zn methionine hydroxy analogue chelate (MINTREX Zn), which is manufactured by Novus International Inc., St. Charles, MO.
cCu-MHAC represents Cu methionine hydroxy analogue chelate (MINTREX Cu), which is manufactured by Novus International Inc., St. Charles, MO.
dThere was a significant interaction (P = 0.03) between Zn sources and phytase. Specifically, when ZnO was used as the Zn source, phytase supplementation increased ADFI during phase 2 by 12.16% (664 vs. 592 g/d) compared with no phytase supplementation, whereas when Zn-MHAC was used as the Zn source, phytase supplementation reduced ADFI during phase 2 by 2.23% (615 vs. 629 g/d) compared with no phytase supplementation.
eThere tended to be an interaction (P = 0.06) between Cu sources and phytase. Specifically, when CuSO4 was used as the Cu source, phytase supplementation increased ADFI during phase 3 by 20.69% (1,021 vs. 846 g/d) compared with no phytase supplementation, whereas when Cu-MHAC was used as the Cu source, phytase supplementation increased ADFI during phase 3 by 9.66% (1,033 vs. 942 g/d) compared with no phytase supplementation.
fThere tended to be an interaction (P = 0.09) between Cu sources and phytase. Specifically, when Cu sulfate was used as the Cu source, phytase supplementation significantly increased G:F during phase 2 by 5.26% (0.80 vs. 0.76 g/g) compared with the group with no phytase supplementation, whereas when Cu-MHAC was used as the Cu source, phytase supplementation significantly increased G:F during phase 2 by 12% (0.84 vs. 0.75 g/g) compared with the group with no phytase supplementation.